U.S. markets open in 5 hours 51 minutes
  • S&P Futures

    4,314.50
    -27.00 (-0.62%)
     
  • Dow Futures

    33,844.00
    -211.00 (-0.62%)
     
  • Nasdaq Futures

    14,086.00
    -72.50 (-0.51%)
     
  • Russell 2000 Futures

    1,950.00
    -22.70 (-1.15%)
     
  • Crude Oil

    87.40
    +0.05 (+0.06%)
     
  • Gold

    1,811.30
    -18.40 (-1.01%)
     
  • Silver

    23.23
    -0.58 (-2.42%)
     
  • EUR/USD

    1.1207
    -0.0038 (-0.34%)
     
  • 10-Yr Bond

    1.8480
    0.0000 (0.00%)
     
  • Vix

    31.98
    +0.82 (+2.63%)
     
  • GBP/USD

    1.3415
    -0.0047 (-0.35%)
     
  • USD/JPY

    114.9120
    +0.2520 (+0.22%)
     
  • BTC-USD

    36,027.39
    -1,596.11 (-4.24%)
     
  • CMC Crypto 200

    820.65
    -35.17 (-4.11%)
     
  • FTSE 100

    7,454.16
    -15.62 (-0.21%)
     
  • Nikkei 225

    26,170.30
    -841.03 (-3.11%)
     

Why Johnson & Johnson Shares Are Trading Higher Today

  • Oops!
    Something went wrong.
    Please try again later.
·1 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.
  • JNJ

Johnson & Johnson (NYSE: JNJ) is trading higher Tuesday after the company announced better-than-expected third-quarter earnings results and raised guidance.

Johnson & Johnson reported quarterly adjusted earnings of $2.60 per share, which beat the estimate of $2.36 per share. The company reported quarterly revenue of $23.34 billion, which came in below the estimate of $23.74 billion.

Johnson & Johnson raised its full-year 2021 earnings guidance from a range of $9.60 to $9.70 per share to a range of $9.77 to $9.82 per share versus the estimate of $9.66 per share.

The company raised its full-year 2021 revenue guidance from a range of $93.8 billion to $94.6 billion to a range of $94.1 billion to $94.6 billion versus the estimate of $94.3 billion.

View more earnings on JNJ

"Our third-quarter results demonstrate solid performance across Johnson & Johnson, driven by robust above-market results in Pharmaceuticals, ongoing recovery in Medical Devices, and strong growth in Consumer Health," said Alex Gorsky, chairman and CEO of Johnson & Johnson.

JNJ Price Action: Johnson & Johnson has traded as high as $179.92 and as low as $133.65 over a 52-week period.

The stock was up 2.83% at $164.65 at time of publication.

Photo: Public Domain from Flickr.

See more from Benzinga

© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.